Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025)
Neurocrine Biosciences (NBIX) posted Exchange Rate Effect of -$200000.0 for Q3 2025, up 33.33% on a QoQ basis from -$300000.0 in Q4 2024, and down 166.67% year-over-year from $300000.0 in Q3 2024.
Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025) Analysis & Trends
Neurocrine Biosciences' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at -$200000.0 for Q3 2025.
- Quarterly Exchange Rate Effect fell 166.67% year-over-year to -$200000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$200000.0 (changed N/A YoY) and the FY2023 annual result came in at $300000.0, up 123.08% from the prior year.
- Exchange Rate Effect was -$200000.0 for Q3 2025 at Neurocrine Biosciences, up from -$300000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $300000.0 in Q4 2023 and bottomed at -$300000.0 in Q4 2024.
- A 3-year average of $25000.0 and a median of $50000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 200.0% — and 2025, when it tumbled 166.67%.
- Neurocrine Biosciences' Exchange Rate Effect stood at $300000.0 in 2023, then plunged by 200.0% to -$300000.0 in 2024, then soared by 33.33% to -$200000.0 in 2025.
- Business Quant data shows NBIX's Exchange Rate Effect at -$200000.0 in Q3 2025, -$300000.0 in Q4 2024, and $300000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -200,000.00 |
| Sep 30, 2025 | -200,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |